The efficacy and safety of immune-checkpoint inhibitors plus chemotherapy versus chemotherapy for non-small cell lung cancer: An updated systematic review and meta-analysis

• Jing Kang,

  Roles Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Software, Validation, Visualization, Writing – original draft, Writing – review & editing

  Affiliations First Hospital of Jilin University, Changchun, China, Jilin Medical University, Jilin, China, Laboratory of Tumor Targeted Therapy and Translational Medicine, Jilin, China

  ⨯
• Jun Zhang,

  Roles Writing – review & editing

  Affiliation Laboratory of Tumor Targeted Therapy and Translational Medicine, Jilin, China

  ⨯
• Zongsheng Tian,

  Roles Writing – review & editing

  Affiliation First Hospital of Jilin University, Changchun, China

  ⨯
• Ye Xu,

  Roles Conceptualization, Data curation, Project administration, Resources, Supervision, Validation, Writing – review & editing

  Affiliations Jilin Medical University, Jilin, China, Laboratory of Tumor Targeted Therapy and Translational Medicine, Jilin, China

  ⨯
• Jiangbi Li,

  Roles Writing – review & editing

  Affiliation First Hospital of Jilin University, Changchun, China

  ⨯
• Mingxian Li

  Roles Conceptualization, Data curation, Project administration, Resources, Supervision, Validation, Writing – review & editing

  * E-mail: mingxian@jlu.edu.cn

  Affiliation First Hospital of Jilin University, Changchun, China

  https://orcid.org/0000-0002-3433-9147

  ⨯